This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Laboratory screening markers are used in medical laboratories to identify certain conditions or diseases. They can also be used to monitor the progression of a disease or treatment. Screening markers are typically proteins that are found in blood or other bodily fluids and are used to detect the presence of a certain disease or condition. Screening markers can be used to detect a wide range of conditions, including cancer, heart disease, diabetes, and infectious diseases. They can also be used to screen for genetic disorders, such as cystic fibrosis, Huntington’s disease, and sickle cell anaemia. Screening markers are usually measured using an ELISA (enzyme-linked immunosorbent assay) or PCR (polymerase chain reaction). ELISAs measure the amount of a particular antigen present in a sample, while PCR detects the presence of a specific gene. The accuracy of screening markers depends on the technique used and the sensitivity of the test. Generally, screening markers are very accurate and can detect even small amounts of the antigen or gene in question. Screening markers are an important tool in the diagnosis of many conditions and diseases. They can provide a quick, reliable result and can help to rule out or confirm a diagnosis.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States